Clinical Trial Update: Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating clove-based therapy in children with relapsed or resistant acute leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Clove (clove extract)

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Acute Leukemia | Phase 2, Phase 3 | Status: COMPLETED